Volume 46, Issue 1 , Pages 47-49, March 2007
Preliminary Descriptive Statistics of the Taiwanese Registry of Epilepsy and Pregnancy for the First 2 Years
Article Outline
Summary
Objective
To present the descriptive statistics of the Taiwanese Registry of Epilepsy and Pregnancy (TREP) for the first 2 years.
Materials and Methods
The pregnancies were recruited from May 2004 to January 2006 with a data format compatible with the International Registry of Antiepileptic Drugs and Pregnancy (EURAP) by referral. The data were collected from either face-to-face interview, telephone interview, or chart review by a research nurse. Five questionnaires (A—E) were required for each pregnancy. The preliminary data for the first 2 years are presented with general descriptive statistics.
Results
Until January 2006, 43 pregnancies have been registered. Questionnaire A was completed in 43 cases, questionnaire B completed in 40 cases, questionnaire C completed in 34 cases, questionnaire D completed in 27 cases, and questionnaire E in eight cases. Among the 39 pregnancies known to take antiepileptic drugs (AEDs) during pregnancy, 28 pregnancies took one AED, nine pregnancies took two AEDs, and two pregnancies took three AEDs. The most commonly used drug was carbamazepine (19/39, 48.72%). Among the 27 pregnancies, who had delivered, the cesarean section rate was 44.44% (12/27), the premature birth rate was 7.41% (2/27), and the fetal malformation rate was 3.7% (1/27).
Conclusion
The preliminary data concluded the efforts of TREP for the first 2 years. Although it is still premature to project a trend out of current data, the registry is expected to provide critical information to local prenatal counseling and contribute further to the international EURAP database.
Key Words: antiepileptic drugs , epilepsy , EURAP , pregnancy , pregnancy registry , TREP
No full text is available. To read the body of this article, please view the PDF online.
References
- EURAP: an international registry of antiepileptic drugs and pregnancy . Epilepsia . 2004;45:1463–1464
- . Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy . Epilepsia . 2004;45:1171–1175
- . Pregnancy registries in epilepsy . Epilepsia . 2001;42:1422–1425
- . Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry . Neurology . 2006;66:354–360
- . Epilepsy and pregnancy: an obstetric perspective . Am J Obstet Gynecol . 2004;190:371–379
- Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital . Epilepsia . 2004;45(Suppl 8):42–47
- . In: Smith's Recognizable Patterns of Human Malformation . Philadelphia: Elsevier Saunders; 2006;p. 652–655
- . Maternal valproate dosage and foetal malformations . Acta Neurol Scand . 2005;112:137–143
- . Valproic acid in epilepsy: pregnancy-related issues . Drug Saf . 2006;29:1–21
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register . J Neurol Neurosurg Psychiatry . 2006;77:193–198
- . Pregnancies of women with epilepsy: a population-based study in Iceland . Epilepsia . 1998;39:887–892
PII: S1028-4559(08)60106-0
doi:10.1016/S1028-4559(08)60106-0
© 2007 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 1 , Pages 47-49, March 2007
